Sales of 67 drug firms grows 5.7 percent in first half: report

Published: 2013-10-04 06:59:00

Updated: 2013-10-04 06:59:00

The combined revenue of 53 pharmaceutical companies listed in listed in Korean Stock Exchange came to 5.38 trillion won in the first half of this year, up 5.7 percent from a year earlier, a government report showed Tuesday.

According to the report by the state-run Korea Health Industry Develop...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK